Literature DB >> 11088063

Chemotherapy in the elderly: pharmacologic considerations.

S M Lichtman1, G Villani.   

Abstract

BACKGROUND: The aging of the population has focused interest on the care of elderly cancer patients. A better understanding of the effects of chemotherapeutic agents on older patients with cancer will help to determine the appropriate use of chemotherapy for this age group.
METHODS: The authors review recent studies and present pharmacokinetic data on several chemotherapeutic agents, particularly those that have recently become available.
RESULTS: Agents such as gemcitabine, vinorelbine, the taxanes, anthracyclines, platinum compounds, topoisomerase I and II inhibitors, and the oral fluoropyrimidines appear to have a beneficial therapeutic index in elderly patients.
CONCLUSIONS: Careful attention to the physiologic changes associated with aging, along with dose adjustments for end-organ dysfunction (eg, renal and hepatic), is necessary to ensure the safe administration of antitumor chemotherapy to the elderly.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11088063     DOI: 10.1177/107327480000700606

Source DB:  PubMed          Journal:  Cancer Control        ISSN: 1073-2748            Impact factor:   3.302


  10 in total

1.  [Urological illnesses in the elderly].

Authors:  J M Wolff
Journal:  Urologe A       Date:  2004-08       Impact factor: 0.639

2.  Feasibility and efficacy of capecitabine and FOLFIRI in patients aged 65 years and older with advanced colorectal cancer: a retrospective analysis.

Authors:  Rafał Stec; Lubomir Bodnar; Cezary Szczylik
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-20       Impact factor: 4.553

3.  Metastatic colorectal cancer in the elderly: An overview of the systemic treatment modalities (Review).

Authors:  Rafał Stec; Lubomir Bodnar; Marta Smoter; Michał Mączewski; Cezary Szczylik
Journal:  Oncol Lett       Date:  2010-11-23       Impact factor: 2.967

Review 4.  Vinorelbine: a review of its use in elderly patients with advanced non-small cell lung cancer.

Authors:  Monique P Curran; Greg L Plosker
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

5.  Chemotherapy in conjoint aging-tumor systems: some simple models for addressing coupled aging-cancer dynamics.

Authors:  Mitra S Feizabadi; Tarynn M Witten
Journal:  Theor Biol Med Model       Date:  2010-06-15       Impact factor: 2.432

6.  Chemotherapy options in elderly and frail patients with metastatic colorectal cancer.

Authors:  Muhammad Wasif Saif
Journal:  Ann Gastroenterol       Date:  2012

7.  Feasibility study of docetaxel plus bevacizumab as first line therapy for elderly patients with advanced non-small-cell lung cancer: Thoracic Oncology Research Group (TORG) 1014.

Authors:  Yusuke Takagi; Yukio Hosomi; Fumihiro Oshita; Hiroaki Okamoto; Nobuhiko Seki; Koichi Minato; Hiromi Aono; Kouzo Yamada; Yusuke Okuma; Naoya Hida; Takahiko Sakamoto; Yosuke Miura; Makiko Yomota; Akira Satoh; Hideo Kunitoh; Kentaro Sakamaki; Masahiko Shibuya; Koshiro Watanabe
Journal:  BMC Cancer       Date:  2015-10-19       Impact factor: 4.430

8.  Geriatric oncology: The need for a separate subspecialty.

Authors:  D K Vijaykumar; R Anupama; Tejal Kishor Gorasia; T R Haleema Beegum; P Gangadharan
Journal:  Indian J Med Paediatr Oncol       Date:  2012-04

9.  Importance of antiresorptive therapies for patients with bone metastases from solid tumors.

Authors:  Draupadi B Talreja
Journal:  Cancer Manag Res       Date:  2012-09-11       Impact factor: 3.989

10.  The risk of early mortality in elderly patients with newly diagnosed acute myeloid leukemia.

Authors:  Chia-Jen Liu; Ying-Chung Hong; Ai Seon Kuan; Chiu-Mei Yeh; Chun-Kuang Tsai; Yao-Chung Liu; Liang-Tsai Hsiao; Hao-Yuan Wang; Po-Shen Ko; Po-Min Chen; Jin-Hwang Liu; Jyh-Pyng Gau
Journal:  Cancer Med       Date:  2020-01-05       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.